Context Therapeutics CNTX
NASDAQ CNTX
$0.22 -0.01 (-4.89%)
As of: Oct 22, 2026 · 10:42 AM EDT

Context Therapeutics (CNTX) Other financing activities (2021 - 2025)

Updated

Analysis

Context Therapeutics (CNTX) Other financing activities (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.12 Bn 1,134.70 Bn 19.71 Bn
2 Johnson & Johnson 634.67 Bn 553.20 Bn 17.26 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn
4 Merck 377.66 Bn 332.04 Bn 12.21 Bn
5 Novartis Ag 303.82 Bn 267.81 Bn 11.24 Bn
6 Astrazeneca 266.80 Bn 240.49 Bn 12.86 Bn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn
8 Gilead Sciences 193.45 Bn 167.65 Bn 6.22 Bn
9 Pfizer 172.20 Bn 118.84 Bn 10.94 Bn
10 Context Therapeutics 20.94 Mn -219.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -15,268.00
Mar 31, 2022 -102,071.00
Dec 31, 2021 716,917.00
Sep 30, 2021 -816,917.00
API Access

Context Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CNTX&period=max&api_key=YOUR_API_KEY